Steven A Rosenberg

发表

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Yingdong Zhao, Richard Simon, Paul H Duray, 2002, Cancer research.

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Seth M Steinberg, Marianna Sabatino, S. Steinberg, 2015, The Lancet.

Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research.

Emanuel F Petricoin, J Carl Barrett, W Marston Linehan, 2003, Clinical advances in hematology & oncology : H&O.

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL.

Alaina Kaiser, Rong Fan, James R Heath, 2018, Blood.

Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma

Stephen C. J. Parker, Valer Gotea, Hannah Carter, 2013, Proceedings of the National Academy of Sciences.

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond.

S. Rosenberg, R. Morgan, P. Robbins, 2007, Cancer research.

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.

Eytan Ruppin, Nir Friedman, Dan Reshef, 2018, Cancer discovery.

Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

Jared Gartner, Bryan Howie, Daniel C Douek, 2016, Cancer Immunology Research.

Two hundred years of cancer research.

V. Devita, S. Rosenberg, Steven A Rosenberg, 2012, The New England journal of medicine.

Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell Therapy

S. Rosenberg, P. Robbins, M. Dudley, 2008, Journal of immunotherapy.

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

S. Rosenberg, C. Klebanoff, N. Restifo, 2005, The Journal of clinical investigation.

HPV-targeted tumor-infiltrating lymphocytes for cervical cancer.

Richard Sherry, S. Rosenberg, J. Yang, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy.

S. Rosenberg, M. Dudley, J. Wunderlich, 2009, Journal of immunological methods.

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

Sadik H. Kassim, M. Raffeld, S. Rosenberg, 2014, Clinical Cancer Research.

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens

Jamie K Teer, Eilon Barnea, Arie Admon, 2016, Oncotarget.

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

John Mao, Francesco M Marincola, F. Marincola, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

S. Rosenberg, M. Dudley, M. Parkhurst, 2012, Journal of Translational Medicine.

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.

S. Rosenberg, M. Ahmadzadeh, Steven A Rosenberg, 2006, Blood.

Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.

W. Burns, S. Rosenberg, P. Muranski, 2011, Blood.

Primary Human T Lymphocytes Engineered with a Codon-Optimized IL-15 Gene Resist Cytokine Withdrawal-Induced Apoptosis and Persist Long-Term in the Absence of Exogenous Cytokine1

S. Rosenberg, R. Morgan, M. Hughes, 2005, The Journal of Immunology.

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

Seth M Steinberg, S. Steinberg, S. Rosenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma

Jamie K Teer, Sean Davis, Xiaomu Wei, 2012, BMC Genomics.

A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer.

W. Burns, S. Rosenberg, R. Morgan, 2014, Human gene therapy.

Specific Increase in Potency via Structure-Based Design of a TCR

Timothy Cardozo, Wei Jun Gu, S. Rosenberg, 2014, The Journal of Immunology.

Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity

Sanja Stevanović, S. Rosenberg, P. Robbins, 2019, Science Immunology.

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

S. Rosenberg, Alexandria P. Cogdill, R. Morgan, 2009, Blood.

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

Seth M Steinberg, S. Steinberg, Helen X. Chen, 2003, The New England journal of medicine.

Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment

Marianna Sabatino, S. Rosenberg, M. Sabatino, 2012, Journal of immunotherapy.

Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma.

Phyu P Aung, S. Rosenberg, P. Robbins, 2014, Human pathology.

Cancer immunotherapy: moving beyond current vaccines

S. Rosenberg, J. Yang, N. Restifo, 2004, Nature Medicine.

Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes

Gang Wang, Gregory Lizée, G. Wang, 2006, Clinical Cancer Research.

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

M. Raffeld, S. Rosenberg, R. Morgan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.

Yangbing Zhao, S. Rosenberg, R. Morgan, 2006, Cancer research.